NYSE · OPY

Oppenheimer Holdings, Inc.

U.S. listed stock · USD15-minute delay

All markets

Find an instrument

Loading price chart…

Price chart by TradingView

15-minute delay. Chart times and available timeframes are controlled by the provider.

Earnings

Earnings calendar

The next earnings date for OPY has not been announced yet.

Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.

News

BNK Invest · The Motley Fool

BNK Invest · Oct 26, 4:20 PM EDTBullish Two Hundred Day Moving Average Cross – OPYIn trading on Monday, shares of Oppenheimer Holdings Inc Class A (D (Symbol: OPY) crossed above their 200 day moving average of $101.90, changing hands as high as $104.55 per share. Oppenheimer Holdings Inc Class A (D shares are currently trading up about 1.7% on the day. The
The Motley Fool · Oct 6, 6:53 PM EDTWhy GE Vernova Stock Trounced the Market TodayHe believes it is better placed than its rivals to surmount the challenges facing the power engineering segment.
The Motley Fool · Oct 4, 9:50 PM EDTCould Investing $5,000 in SpaceX Help Make You a Millionaire?SpaceX has a market cap of $2 trillion, leaving millionaire-making returns for investors nearly impossible to achieve.
The Motley Fool · Sep 25, 4:31 AM EDTWhy Turning Point Brands Stock Was Sliding This WeekIts CEO resigned unexpectedly.
The Motley Fool · Sep 17, 7:05 AM EDTWall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic.VK2735's dual formulation and rapid weight loss onset could be key differentiators provided the phase 3 trials are successful.
The Motley Fool · Sep 3, 4:50 PM EDT3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're WrongViking Therapeutics' shares could soar as it makes progress with its leading candidates.
The Motley Fool · Jul 13, 9:58 PM EDTWhy Q32 Bio Stock Skyrocketed TodayQ32 Bio is striving to develop a safe and effective therapy for alopecia areata.
The Motley Fool · Jun 28, 5:27 PM EDTWall Street Sees SpaceX Surpassing Nvidia in Long-Term ValuationMultiple Wall Street analysts have set lofty targets for SpaceX, high enough that it could surpass Nvidia.
The Motley Fool · Jun 25, 7:25 PM EDTI'd Buy More of This Growth Stock Before the Market Figures Out What It's MissingTesla stock trades at nosebleed levels thanks to its AI exposure.
The Motley Fool · Jun 24, 5:32 AM EDTThe S&P 500 Is Up 9% in 2026. Wall Street Says the Stock Market Will Do This Next.The S&P 500 has returned 9% this year despite rich valuations and economic uncertainty tied to tariffs and the Iran war.
The Motley Fool · Jun 20, 6:20 AM EDTSpaceX Stock Surged 30% After Its IPO. Here's Where It's Going Next, According to 2 Wall Street AnalystsSpaceX stock hit the Nasdaq at $150 per share, and took off after that.
The Motley Fool · Jun 18, 4:58 AM EDT6 Wall Street Analysts Have Issued Price Targets on SpaceX. Here's the One I Agree With Most.Analyst price targets and earnings projections are important because they help set a baseline for a stock.

Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.

Company profile

Loading company profile…

Company profile by TradingView

Financials

Loading fundamental data…

Fundamental data by TradingView

More headlines

More stories for Oppenheimer Holdings, Inc. from TradingView. Coverage varies.

Loading related news…